Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2015 Jul;25(6):1015–1022. doi: 10.1097/IGC.0000000000000453

Table 5.

Multivariate Analysis of Serum Platelet Level and Survival

Disease Free Survival Disease Specific Survival
Hazard ratio 95% CI P Hazard ratio 95% CI P
Patient Characteristics
  Age 1.01 0.99, 1.03 0.2 1.01 0.98, 1.03 0.61
Race * * * 0.8 0.38, 1.68 0.56
  Radiation therapyµ 0.19 0.11, 0.34 <0.001 0.33 0.19, 0.6 <0.001
  Serum platelet level 2.24 1.26, 3.98 <0.01 1.03 0.56, 1.88 0.93
  Serum CA-125 level 1.00 1.00, 1.00 0.001 1.001 1.000, 1.001 0.014
Tumor Characteristics
  Stage 1.54 0.89, 2.65 0.12 1.35 0.76, 2.42 0.31
  Grade 5.13 1.59, 16.67 <0.01 8.29 2.01, 4.25 <0.01
  LVSI 1.72 0.78, 3.80 0.18 1.27 0.63, 2.56 0.5

Only those variables significant in univariate analysis are included

*

no data presented because not included in analysis.

µ

Includes EBRT, vaginal brachytherapy, or a combination of both